Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone

There were similar and, in some instances, more favorable neonatal and maternal outcomes for pregnancies exposed to buprenorphine combined with naloxone compared with buprenorphine alone. For the outcomes assessed, compared with buprenorphine alone, buprenorphine with naloxone during pregnancy appears to be a safe treatment option. This supports the view that both formulations are reasonable options for the treatment of opioid use disorder in pregnancy, affirming flexibility in collaborative treatment decision-making.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2024-08-12
DOI
https://doi.org/10.1001/jama.2024.11501
Citations
11
Primary Topic
Prenatal Substance Exposure Effects
Type
article
Field-Weighted Citation Impact
12.20
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone

Yanmin Zhu, Kathryn J. Gray, Sonia Hernández–Dı́az, Loreen Straub et al.
11 citations
JAMA
Prenatal Substance Exposure Effects
12.20
article

Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone

Yanmin Zhu, Kathryn J. Gray, Sonia Hernández–Dı́az, Loreen Straub, Mishka Terplan, Krista F. Huybrechts, Jonathan M. Davis, Hilary S. Connery, Brian T. Bateman, Hendrée E. Jones, Seanna Vine, Barry Lester, Heidi Zakoul, Elizabeth A. Suarez, Helen Mogun
article en
11 citations

Abstract

There were similar and, in some instances, more favorable neonatal and maternal outcomes for pregnancies exposed to buprenorphine combined with naloxone compared with buprenorphine alone. For the outcomes assessed, compared with buprenorphine alone, buprenorphine with naloxone during pregnancy appears to be a safe treatment option. This supports the view that both formulations are reasonable options for the treatment of opioid use disorder in pregnancy, affirming flexibility in collaborative treatment decision-making.

JAMAVol. 332(10)
Rutgers, The State University of New Jersey (US), University of North Carolina at Chapel Hill (US), Brigham and Women's Hospital (US), Tufts Medical Center (US), Harvard University (US), Providence College (US), University of Washington (US), Brown University (US), McLean Hospital (US), Women & Infants Hospital of Rhode Island (US), Friends Research Institute (US), Stanford University (US)
Good health and well-being
Openalex Percentile: Top 1%
Prenatal Substance Exposure Effects
12.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.